California Public Employees Retirement System decreased its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 31.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 214,794 shares of the company’s stock after selling 99,053 shares during the quarter. California Public Employees Retirement System’s holdings in Clorox were worth $22,259,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of CLX. Darwin Wealth Management LLC acquired a new position in Clorox during the 2nd quarter valued at about $29,000. Caitlin John LLC grew its position in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares during the period. Root Financial Partners LLC raised its stake in shares of Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after buying an additional 145 shares during the last quarter. Vision Financial Markets LLC lifted its holdings in Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after buying an additional 200 shares during the period. Finally, SHP Wealth Management acquired a new position in Clorox in the fourth quarter valued at approximately $35,000. 78.53% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
CLX has been the subject of a number of analyst reports. Wells Fargo & Company lowered their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a report on Monday, May 18th. Morgan Stanley reduced their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Evercore reaffirmed an “underperform” rating and set a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. UBS Group upped their price objective on Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a report on Thursday, July 16th. Finally, The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat, Clorox presently has an average rating of “Reduce” and an average price target of $103.60.
Insiders Place Their Bets
In related news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.63% of the company’s stock.
Clorox Stock Up 0.0%
Shares of Clorox stock opened at $95.72 on Thursday. The company has a market capitalization of $11.57 billion, a P/E ratio of 15.54 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The business has a 50-day moving average of $94.94 and a two-hundred day moving average of $103.94. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the business posted $1.45 EPS. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts predict that The Clorox Company will post 5.52 EPS for the current year.
Clorox Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Articles
- Five stocks we like better than Clorox
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
